PCR detection of Toxoplasma gondii DNA in CSF for the differential diagnosis of AIDS-related focal brain lesions

Journal of Medical Microbiology

Volumn 45, Issue 6, 1996, Pages 472-476

  Cingolani, Antonella ^a   De Luca, Andrea ^a   Ammassari, Adriana ^a   Murri, Rita ^a   Linzalone, Angela ^a   Grillo, Rita ^a   Antinori, Andrea ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ATOVAQUONE; CLINDAMYCIN; PYRIMETHAMINE; SULFADIAZINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; BRAIN INJURY; CEREBROSPINAL FLUID; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TOXOPLASMA GONDII; TOXOPLASMOSIS;

EID: 0029908690     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/00222615-45-6-472     Document Type: Article

References (22)

1. Bacellar H, Munoz A, Miller EN et al. Temporal trends in the incidence of HIV-1-related neurologic diseases. Multicenter AIDS cohort study, 1985-1992. Neurology 1994; 44: 1892-1900.
2. Centers for Disease Control. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morh Mortal Wkly Rep 1992; 41 (RR17): 1-19.
3. Girard P-M, Landman R, Gaudebout C et al. Dapsonepyrimethamine compared with aerosolized pentamidine as primary prophylaxis against Pneumocystis carinii pneumonia and toxoplasmosis in HIV infection. N Engl J Med 1993; 328: 1514-1520.
4. Antinori A, Murri R, Ammassari A et al. Aerosolized pentamidine, cotrimoxazole and dapsone-pyrimethamine for primary prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis. AIDS 1995; 9: 1343-1350.
5. Grover CM, Thulliez P, Remington JS, Boothroyd JC. Rapid prenatal diagnosis of congenital toxoplasma infection by using polymerase chain reaction and amniotic fluid. J Clin Microbiol 1990; 28: 2297-2301.
6. Weiss LM, Udem SA, Salgo M, Tanowitz HB, Wittner M. Sensitive and specific detection of toxoplasma DNA in an experimental murine model: use of T. gondii-specific cDNA and the polymerase chain reaction. J Infect Dis 1991; 163: 180-186.
7. Bretagne S, Costa J-M, Fleury-Feith J, Poron F, Dubreuil-Lemaire M-L, Vidaud M. Quantitative competitive PCR with bronchoalveolar lavage fluid for diagnosis of toxoplasmosis in AIDS patients. J Clin Microbiol 1995; 33: 1662-1664.
8. Verhofstede C, Reniers S, Colebunders R, van Wanzeele F, Plum J. Polymerase chain reaction in the diagnosis of Toxoplasma encephalitis. AIDS 1993; 7: 1539-1541.
9. Schoondermark-van de Ven E, Galama J, Kraaijeveld C, van Druten J, Meuwissen J, Melehers W. Value of polymerase chain reaction for the detection of Toxoplasma gondii in cerebrospinal fluid from patients with AIDS. Clin Infect Dis 1993; 16: 661-666.
10. Novati R, Castagna A, Morsica G et al. Polymerase chain reaction for Toxoplasma gondii DNA in cerebrospinal fluid of AIDS patients with focal brain lesions. AIDS 1994; 8: 1691-1694.
11. Dupon M, Cazenave J, Pellegrin J-L et al. Detection of Toxoplasma gondii by PCR and tissue culture in cerebrospinal fluid and blood of human immunodeficiency virus-seropositive patients. J Clin Microbiol 1995; 33: 2421-2426.
12. Eggers C, Gross U, Klinker H, Schalke B, Stellbrink HJ, Kunze K. Limited value of cerebrospinal fluid for direct detection of Toxoplasma gondii in toxoplasmic encephalitis associated with AIDS. J Neurol 1994; 242: 644-649.
13. De Luca A, Cingolani A, Linzalone A et al. Improved detection of JC virus DNA in cerebrospinal fluid for the diagnosis of AIDS-related progressive multifocal leukoencephalopathy. J Clin Microbiol 1996; 34: 1343-1346.
14. De Luca A, Antinori A, Cingolani A et al. Evaluation of cerebrospinal fluid EBV-DNA and IL-10 as markers for in vivo diagnosis of AIDS-related primary central nervous system lymphoma. Br J Haematol 1995; 90: 844-849.
15. Aurelius E, Johansson B, Sköldenberg B, Staland A, Forsgren M. Rapid diagnosis of herpes simplex encephalitis by nested polymerase chain reaction assay of cerebrospinal fluid. Lancet 1991; 337: 189-192.
16. Lehech M, Lebech A-M, Nelsing S, Vuust J, Mathiesen L, Petersen E. Detection of Toxoplasma gondii DNA by polymerase chain reaction in cerebrospinal fluid from AIDS patients with cerebral toxoplasmosis. J Infect Dis 1992; 165: 982-983.
17. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual. 2nd edn. Cold Spring Harbor, New York, Cold Spring Harbor Laboratory Press. 1989.
18. Sackett DL, Haynes RB, Guyatt GH, Tugwell P. The interpretation of diagnostic data. In: Clinical epidemiology. A basic science for clinical medicine, 2nd edn. Boston, Little Brown and Company. 1991: 69-152.
19. Ammassari A, Murri R, Cingolani A, De Luca A, Antinori A. AIDS-associated cerebral toxoplasmosis: an update on diagnosis and treatment. Curr Top Microbiol Immunol 1996 (in press).
20. Mathews C, Barba D, Fullerton SC. Early biopsy versus empiric treatment with delayed biopsy of non-responders in suspected HIV-associated cerebral toxoplasmosis: a decision analysis. AIDS 1995; 9: 1243-1250.
21. Forsyth PA, Yahalom J, DeAngelis LM. Combined-modality therapy in the treatment of primary central nervous system lymphoma in AIDS. Neurology 1994; 44: 1473-1479.
22. Pierce MA, Johnson MD, Maciunas RJ et al. Evaluating contrast-enhancing brain lesions in patients with AIDS by using positron emission tomography. Ann Intern Med 1995; 123: 594-598.